Joakim Nyberg

8PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsToxicology (incl. clinical toxicology)Time-series analysisGene and molecular therapyBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2026
Objective First, Method Second: Why the Estimand Definition Comes First in Pharmacometric Covariate Modeling.

E Niclas Jonsson, Joakim Nyberg, France Mentré

|Jan 28, 2026
Conditional Versus Unconditional Covariate Effects in Pharmacometric Models: Implications for Interpretation, Communication, and Reporting.

E Niclas Jonsson, Siv Jönsson, Emma Hansson

|Feb 22, 2025
The impact of misspecified covariate models on inclusion and omission bias when using fixed effects and full random effects models.

Joakim Nyberg, E Niclas Jonsson

|Jun 28, 2024
Full random effects models (FREM): A practical usage guide.

E Niclas Jonsson, Joakim Nyberg

|Feb 28, 2024
Using forest plots to interpret covariate effects in pharmacometric models.

E Niclas Jonsson, Joakim Nyberg

|Jan 04, 2024
Subcutaneous Marzeptacog Alfa (Activated) for On-Demand Treatment of Bleeding Events in Subjects With Hemophilia A or B With Inhibitors.

Alan Faraj, Joakim Nyberg, Grant E Blouse

Pageof 2